Targeted Genetics Aims To Reinitiate Arthritis Gene Therapy Trial By December
Data reviewed by NIH Recombinant DNA Advisory Committee suggest it is unlikely the experimental therapy contributed to a patient’s death in July, CEO says.
Data reviewed by NIH Recombinant DNA Advisory Committee suggest it is unlikely the experimental therapy contributed to a patient’s death in July, CEO says.